Medifast, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medifast, Inc.'s yearly results (2022–2025), compared with Consumer Cyclical companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than almost all Consumer Cyclical companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.2 times its market value (net cash). Higher than almost all Consumer Cyclical companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 9.2 times. Higher than 91% of Consumer Cyclical companies in United States.
Cash quality
Profit Cash Ratio
$216Over the last 3 years, every $100 of reported profit came with $216 of operating cash.
Higher than 74% of Consumer Cyclical companies in United States.
Self-Funding Ratio
9.2×Over the last 3 years its own operating cash covered its investment spending (capex) 9.2 times.
Higher than 91% of Consumer Cyclical companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than almost all Consumer Cyclical companies in United States.
Growth Efficiency Ratio
—Sales fell 76%
Sales fell 76% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-76% / -22%In 3 years sales changed by -76% while total assets changed by -22%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
1.5×Debt due within a year is covered 1.5 times by its yearly operating cash.
Lower than 62% of Consumer Cyclical companies in United States.
Cash Cushion Ratio
1.2× cashCash, after subtracting all debt, is 1.2 times its market value (net cash).
Higher than almost all Consumer Cyclical companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Medifast, Inc. made a loss over the last year. Medifast, Inc. owes $0.25 for every $1 it owns. Medifast, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Compared with Consumer Cyclical companies in United States · latest annual results Dec 2025.
P/E ratio
LossMedifast, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.69The share price is 0.69 times Medifast, Inc.'s book value per share, lower than 89% of Consumer Cyclical companies in United States.
Market cap
$136 MThe total market value of all of Medifast, Inc.'s shares at today's price (share price × number of shares), smaller than 81% of Consumer Cyclical companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$196 MWhat Medifast, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$17.56Net worth divided by the number of shares. The share price of $12.17 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-12.4%Medifast, Inc. lost 12.4% of its shareholders' money over the last year, lower than 76% of Consumer Cyclical companies in United States.
Owes vs Owns
0.25×Medifast, Inc. owes $0.25 for every $1 it owns (low), lower than 94% of Consumer Cyclical companies in United States.
Dividend yield
NoneMedifast, Inc. does not currently pay a dividend.
Revenue growth
-36%Revenue fell 36% in the year to Dec 2025, and shrank 38% a year on average over 3 years.
Profit growth
LossMedifast, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-4.8%Medifast, Inc. lost $5 for every $100 of revenue.
Cash vs debt
Net cashMedifast, Inc. held $157 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medifast, Inc.: $136 M ÷ $196 M (30 Jun 2026) = 0.7.
What is Medifast, Inc.'s return on equity?
Medifast, Inc. lost 12.4% of its shareholders' money over the last year, lower than 76% of Consumer Cyclical companies in United States.
How much does Medifast, Inc. owe compared with what it owns?
Medifast, Inc. owes $0.25 for every $1 it owns (low), lower than 94% of Consumer Cyclical companies in United States.
Does Medifast, Inc. pay a dividend?
No. Medifast, Inc. does not currently pay a dividend.
Is Medifast, Inc.'s revenue growing?
Revenue fell 36% in the year to Dec 2025, and shrank 38% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.